Requires covered entities report to the department of health regarding certain 340B drug discounts

The bill was amended to add two new sponsors and recommit it to the Health Committee for further review. The effective date of the reporting requirements was delayed from April 1, 2026, to April 1, 2027, likely to allow covered entities more time to prepare. Additionally, a new exemption was added to exclude Federally Qualified Health Centers from the definition of a covered entity, ensuring they are not subject to these specific 340B drug reporting mandates.